Joerg F. Hipp

Hugstetter Str. 55
Freiburg, BW 79106, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Linking human brain functional connectivity to underlying neurotransmission.

Linking human brain functional connectivity to underlying neurotransmission.

Journal: bioRxiv : the preprint server for biology

Published: May 07, 2026

Digital Twin Brain simulation and manipulation of a functional brain network underlying mental illness.

Digital Twin Brain simulation and manipulation of a functional brain network underlying mental illness.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

Excess EEG beta-band oscillations in Dup15q syndrome correlate with clinical severity.

Excess EEG beta-band oscillations in Dup15q syndrome correlate with clinical severity.

Journal: Translational psychiatry

Published: July 03, 2025

Clinically altered brain activity may not look like aged brain activity: Implications for brain-age modeling and biomarker strategies.

Clinically altered brain activity may not look like aged brain activity: Implications for brain-age modeling and biomarker strategies.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: May 09, 2025

Preclinical pharmacology of alogabat: a novel GABAA-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABAA signaling.

Preclinical pharmacology of alogabat: a novel GABAA-α5 positive allosteric modulator targeting neurodevelopmental disorders with impaired GABAA signaling.

Journal: Frontiers in pharmacology

Published: May 09, 2025

Qualitative EEG abnormalities in ASD reflect inhibition-dominated brain dynamics.

Qualitative EEG abnormalities in ASD reflect inhibition-dominated brain dynamics.

Journal: Scientific reports

Published: March 05, 2025

Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeys.

Angelman syndrome patient-derived neuron screen leads to clinical ASO rugonersen targeting UBE3A-ATS with long-lasting effect in monkeys.

Journal: Nucleic acids research

Published: February 10, 2025

The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial.

The UBE3A-ATS antisense oligonucleotide rugonersen in children with Angelman syndrome: a phase 1 trial.

Journal: Nature medicine

Published: January 13, 2025

Local activity alterations in autism spectrum disorder correlate with neurotransmitter properties and ketamine induced brain changes.

Local activity alterations in autism spectrum disorder correlate with neurotransmitter properties and ketamine induced brain changes.

Journal: medRxiv : the preprint server for health sciences

Published: November 06, 2024

Benchmarking the utility of dry-electrode electroencephalography for clinical trials.

Benchmarking the utility of dry-electrode electroencephalography for clinical trials.

Journal: Scientific reports

Published: November 06, 2024

Local activity alterations in individuals with autism correlate with neurotransmitter properties and ketamine-induced brain changes.

Local activity alterations in individuals with autism correlate with neurotransmitter properties and ketamine-induced brain changes.

Journal: Nature communications

Published: November 04, 2024

RO4938581, a GABAA-α5 negative allosteric modulator rescued behavioral and EEG phenotypes of a mouse model of Dup15q syndrome.

RO4938581, a GABAA-α5 negative allosteric modulator rescued behavioral and EEG phenotypes of a mouse model of Dup15q syndrome.

Journal: Molecular psychiatry

Published: October 30, 2024

Showing 1-12 of 72

Last Updated: 09/26/2026